Chondroitin Sulfate Synthase 3 (CHSY3) (N-Term) Peptide
CHSY3
适用: 人
宿主: 合成
BP, WB
产品编号 ABIN974980
发货至:
中国
Contact our Customer Service for availability and price in your country.
Contact Info
Our Local Distributor
中国
北京 101111
北京 101111
No. 88 KeChuang 6th Street
Beijing Economic Technological Development Area
Room 801-803
Quick Overview for Chondroitin Sulfate Synthase 3 (CHSY3) (N-Term) Peptide (ABIN974980)
抗原
CHSY3
(Chondroitin Sulfate Synthase 3 (CHSY3))
宿主
人
资源
合成
应用范围
Blocking Peptide (BP), Western Blotting (WB)
-
-
蛋白结构域
- N-Term
-
产品特性
- This is a synthetic peptide designed for use in combination with anti-CHSY-2 antibody (Catalog #: ARP49126_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
-
纯化方法
- Purified
-
-
-
-
应用备注
- Each Investigator should determine their own optimal working dilution for specific applications.
-
限制
- 仅限研究用
-
-
-
状态
- Lyophilized
-
溶解方式
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
-
浓度
- 1 mg/mL
-
缓冲液
- Final peptide concentration is 1 mg/mL in PBS.
-
注意事项
- Avoid repeated freeze-thaw cycles.
-
储存条件
- -20 °C
-
储存方法
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
-
- CHSY3 (Chondroitin Sulfate Synthase 3 (CHSY3))
-
背景
-
CHSY-2 has both beta-1,3-glucuronic acid and beta-1,4-N-acetylgalactosamine transferase activity. CHSY-2 transfers glucuronic acid (GlcUA) from UDP-GlcUA and N-acetylgalactosamine (GalNAc) from UDP-GalNAc to the non-reducing end of the elongating chondroitin polymer. Specific activity of CHSY-2 is much reduced compared to CHSY1.CSS3 is a glycosyltransferase that has both glucuronyltransferase and N-acetylgalactosaminyltransferase activities (Yada et al., 2003 [PubMed 12907687]).[supplied by OMIM].
Alias Symbols: CHSY2, CSS3, CHSY-2
Protein Size: 882 -
分子量
- 100 kDa
-
基因ID
- 337876
-
NCBI登录号
- NM_175856, NP_787052
-
UniProt
- Q70JA7
抗原
-
You are here:
